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Abstract
A universal microchip was developed for genotyping Influenza A viruses. It contains two sets of oligonucleotide probes
allowing viruses to be classified by the subtypes of hemagglutinin (H1–H13, H15, H16) and neuraminidase (N1–N9).
Additional sets of probes are used to detect H1N1 swine influenza viruses. Selection of probes was done in two steps.
Initially, amino acid sequences specific to each subtype were identified, and then the most specific and representative
oligonucleotide probes were selected. Overall, between 19 and 24 probes were used to identify each subtype of
hemagglutinin (HA) and neuraminidase (NA). Genotyping included preparation of fluorescently labeled PCR amplicons of
influenza virus cDNA and their hybridization to microarrays of specific oligonucleotide probes. Out of 40 samples tested, 36
unambiguously identified HA and NA subtypes of Influenza A virus.
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Introduction
Influenza A virus circulating among humans and domestic and
wild animals presents a significant pandemic threat due to the
rapid evolution of strains with new antigenic properties [1].
Examples include the recent emergence of H1N1 swine influenza
virus that proved pathogenic for humans, as well as H5N1 bird
influenza virus that has the capacity to become pathogenic for
domestic birds and humans.
Since protection against influenza is determined primarily by
HA and NA antigens, it is important to classify new isolates by
subtypes of these proteins. Presently, 16 sub-types of HA and 9
sub-types of NA are known [2,3]. The traditional scheme of sub-
typing influenza viruses involves virus isolation, analysis using
standard immunochemical techniques or real-time PCR amplifi-
cation, and partial or complete nucleotide sequencing of HA and
NA genes [4,5,6,7].
Recently, microchip hybridization has become a popular
diagnostic tool [8,9,10,11,12,13,14,15,16,17,18,19,20,21,22]. Two
types of microchips are used for this purpose: sequencing and
hybridization microchips. In the first case, the use of microchip and
micro-fluidics technology is used for determination of nucleotide
sequences of HA and NA needed for the classification of viruses
[14,19,20]. More commonly, hybridization microchips use sets of
immobilized oligonucleotideprobesthat form complexes with virus-
specific cDNA tagged with, for instance, a fluorescent label
[9,13,17,21,22]. In these papers specialized microchips were used
to determine a limited number of influenza virus types [9,13], as
well as microchips for sub-typing the majority of HA and NA
variants [20]. Some protocols use PCR amplification with primers
specific to select sub-types of HA and NA [22]. These protocols
increasespecificitybycomplicatingtheoverallprocedure.Efficiency
of any microchip hybridization protocol is determined by the
procedure used to identify specific probes to distinguish between
genotypes. The task of probe selection is relatively straightforward
when sequences differ significantly, as is the case for the genotyping
of higher taxa. For instance, it is very easy to discriminate herpes
and pox-viruses [23].
The task becomes more complicated if genomic structures are
similar. Probe selection becomes even more complicated when the
number of known sequences is very large and exceeds several
hundreds and even thousands. In this case, the strategy of probe
selection becomes critical.
There are several published approaches and algorithms
[24,25,26,27,28,29,30,31] for the analysis of DNA sequences
and selection of specific probes. Directly searching for probes
based on traditional computational methods is labor-intensive and
often requires much time. Probe selection could be simplified for
the initial analysis of protein sequences that are more conservative.
This approach was discussed in several communications [26,31]
but was not fully implemented because of the differences in amino
acid and nucleotide sequences of the microorganisms. This
approach could have a better chance of success for analyzing
closely related DNA sequences such as cDNA of Influenza A and
B viruses.
Considering the short length of HA and NA genes (1700 and
1400 nucleotides, respectively), finding a set of probes specific to
each sub-type of HA and NA is not simple. First, there is a
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the cDNA structure of different sub-types of HA depends on the
sub-type of NA present in the virus, and vice versa. This
complicates the selection of probes specific to the entire sub-type
regardless of the matching NA sub-type (e.g., H1N1, H1N2, …
H1N9). In this study, we have explored the selection of probes
based on amino acid sequences to create a universal microchip
that could determine all sub-types of HA and NA of Influenza A
virus.
Results and Discussion
The selection of microarray probes was performed in two steps
using custom software developed in our lab. During the first phase,
amino acid sequences typical of the sub-type of interest, but absent
from other sub-types, were identified. During the second phase,
oligonucleotide probes were derived from these conserved peptides
and their properties optimized. The rationale for this approach is
that microorganism properties are determined mostly by amino
acid sequences, rather than nucleotide sequences. In addition,
amino acid sequences are more conserved, which simplifies the
search for similar sequences.
The process that will be illustrated using the example of the NA
gene included the following steps (Fig. 1):
N Selection of nucleic sequences from GenBank and their
translation into polypeptides
N Selection of peptides common for the NA sub-type of interest
N Removal of peptides present in other sub-types of NA
N Reverse translation of these peptides into nucleic acid probes
N Selection of the most representative probes
N Removal of oligonucleotide probes that can bind other NA
sub-types after one or two mutations
N Selection of probes forming duplexes with target DNA with
optimal melting temperatures
Selection of conserved peptide sequences
Genomic sequence databases contain a number of incomplete
sequences that complicate selection of universal probes. Therefore
only protein sequences longer than 200 amino acids were
analyzed. Conserved stretches of seven amino acids were identified
among peptides from each sub-type of NA, regardless of a
matching HA sub-type. This peptide length was chosen because
using a longer stretch would significantly reduce the number of
oligonucleotide probes typical for each sub-type, and shorter
peptides would produce less specific probes. Because it was not
possible to find peptides common to all proteins of the same sub-
type (due to sequence variability and because some genes were not
completely sequenced), the most common peptides that were
present in more than 90%–95% of the proteins were selected.
Next, peptides unique for the serotype of NA were selected by
removing peptides also found in other sub-types. Therefore, nine
sets of peptides that were 7 amino acids in length identifying each
sub-type of NA were selected.
The example below presents the amino acid sequence of the NA
of A/California/UR06-0552/2007(H1N1) isolate. Peptides shown
in bold italics are typical for 90% of N1 subtype neuraminidase,
while absent from all other sub-types (N2–N9). There was a total
of 89 such 7-mer peptides.
MNPNQKIITIGSISIAIGIISLMLQIGNIISIWASHSIQTGS-
QNHTGICNQRIITYENSTWVNHTYVSINNTNVVAGKDK-
TSVTLAGNSSLCSISGWAIYTKDNSIRIGSKGDVFVIREPF-
ISCSHLECRTFFLTQGALLNDKHSNGTVKDRSPYRALMS-
CPLGEAPSPYNSKFESVAWSASACHDGMGWLTIGISGPD-
NGAVAVLKYNGIITETIKSWKKRILRTQESECVCVNGSC-
FTIMTDGPSNGAASYKIFKIEKGKVTKSIELNAPNFHYEE-
CSCYPDTGTVMCVCRDNWHGSNRPWVSFNQNLDYQIG-
YICSGVFGDNPRPKDGKGSCNPVTVDGADGVKGFSYKY-
GNGVWIGRTKSNRLRKGFEMIWDPNGWTDTDSDFSVK-
QDVVAITDWSGYSGSFVQHPELTGLDCIRPCFWVELVRG-
LPRENATIWTSGSSISFCGVDSDTANWSWPDGAELPFTIDK
Selection of oligonucleotide probes
The conserved 7-mer peptides were reverse translated into the
respective sets of 21-mer oligonucleotides. If peptides partially
overlapped with a shift of one or two amino acids, then the
corresponding oligonucleotide probes would produce largely
redundant information about the sub-type of NA. In these cases
only one such probe was selected using the following criteria. Let
us consider peptide segment LAGNSSLC, represented by two 7-
mer peptides: LAGNSSL and AGNSSLC. For these peptides, sets
of 51 and 43 oligonucleotide probes were generated (Table 1).
Selection of one of these two sets was made based on the following
criteria:
1. Out of several sets of oligonucleotide probes sorted by the
number of times each one was found in the set of analyzed
sequences, the set in which the first probe was most represented
was selected.
2. If the representation of the first probe was equal, then selection
was based on the first two probes.
3. Again, if the representation was equal, the set with the minimal
number of probes was selected.
If all parameters in the above steps were equal, then the set was
selected randomly; frequently, the first set was chosen.
Figure 1. Scheme of the selection of oligonucleotide probes.
doi:10.1371/journal.pone.0017529.g001
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oligonucleotide sequences, met these criteria. Out of these oligonu-
cleotide sequences, probe number 1 (TTAGCGGGCAATT-
CATCTCTT) was present in 1043 sequences of NA genes, while
probe number 2 (TTGGCCGGCAATTCATCTCTT) was present
in 708 out of the total 2696 analyzed NA sequences of this sub-type.
For other probes, these numbers were significantly lower. If the
continuous conserved peptide was long, as for REPFISCSH-
LECRTFFLTQGALLNDKHSNGTVKDRSP (see amino acid
sequence of A/California/UR06-0552/2007[H1N1] isolate), several
overlapping peptides shifted 3–7 amino acids relative to each
other were selected to maximize the use of independent sequence
information.
Principles used for the selection of probes for other sub-types of
neuraminidase (N2–N9) were similar to the above example.
Evidently, the number of oligonucleotide probes for the entire set
of peptides can be very high, reaching several thousands. Many
represent only one viral cDNA sequence (Table 1). Therefore, the
next step was selection of the sub-set of an optimal size (20–24
probes), maximizing the chances of successful determination of NA
sub-types. The simplest solution would be to choose only highly
represented probes. However, the downside of this approach is
that the procedure would be biased for probes specific to variants
of NA from viruses containing the most prevalent sub-type of HA.
Therefore we have used a special procedure to ensure more
uniform representation of sequences.
Reducing representation bias
The existing nucleotide databases predominantly contain
sequences of NA gene of sub-types N1 and N2, while there is
significantly less information about other sub-types. Similarly, the
HA gene is mostly represented by sub-types H1, H3, and H5. In
addition, within each sub-type of NA sequences of different
matching sub-types of HA are also not represented equally (Tables
S1 and S2). For instance, the N1 genotype is predominantly
matched with sub-types H1 (1140 out of 2696 sequences or 42% of
the database) and H5 (1295 or 48%), while some other HA sub-
types were under-represented (H4, H10, H12) or absent altogether
(H8, H13, H14, H15). The correlation between the structure of
the NA gene and the type of HA is determined by coevolution of
Influenza A viruses: changes in one gene are accompanied by
changes in other genes [32,33].
To minimize the representation bias, the following approach
was used (Fig. 2). First, the probe (Probe_1-1) most represented in
all sequences (Seq_0) was selected from the entire set of probes
(Probe_Total). Next, sequences containing Probe_1-1 were
removed from Seq_0, producing a smaller set Seq_1. Next,
Probe_1-2 that was represented most in Seq_1 was identified and
removed from the set. This iterative operation was repeated to
generate Probe_1-3, Probe_1-4, Probe_1-5, and Probe_1-6.
During the next phase, the first six probes (Probe_1-1–Probe_
1-6) were removed from the entire pool of probes (Probe_Total),
and the remaining probes were subjected to the same selection
procedure using the entire starting DNA database Seq_0 to
generate an additional set of probes Probe_2-1–Probe_2-6. The
entire procedure was repeated three more times to create three
additional sets of six probes. The structures of the resulting 30
probes are presented in Table S3.
Table 1. Oligonucleotide probes for N1 neuraminidase
generated for LAGNSSL and AGNSSLC peptides.
# LAGNSSL # AGNSSLC
1 TTAGCGGGCAATTCATCTCTT-
(1043)*
1 GCGGGCAATTCATCTCTTTGC-
(1022)
2 TTGGCCGGCAATTCATCTCTT- (708) 2 GCCGGCAATTCATCTCTTTGT- (769)
3 TTAGCCGGCAATTCATCTCTT- (121) 3 GCAGGCAATTCCTCTCTCTGT- (94)
4 CTAGCAGGCAATTCCTCTCTC- (98) 4 GCCGGCAATTCATCTCTTTGC- (76)
5 CTAGCCGGCAATTCCTCTCTT- (62) 5 GCCGGCAATTCCTCTCTTTGC- (69)
6 TTAGCGGGCAATTCCTCTCTC- (61) 6 GCGGGCAATTCCTCTCTCTGC- (67)
7 TTGGCAGGCAATTCGTCTCTT- (37) 7 GCGGGCAATTCATCTCTTTGT- (41)
.............................. ..............................
42 CTAGCAGGTAATTCCTCTCTT- (1) 42 GCGGGTAATTCCTCTCTCTGC- (1)
43 CTAGCAGGCAATTCTTCTCTC- (1) 43 GCGGGAAATTCATCTCTTTGC- (1)
44 CTAGCAGGCAACTCCTCTCTC- (1)
45 TTGGCCGGTAATTCATCTCTT- (1)
46 TTAGCCGGCAATTCATCTCTC- (1)
47 CTAGCGGGCAACTCCTCTCTC- (1)
48 TTGGCCGGCAATTCATCTCTC- (1)
49 CTAGCGGGCAATTCATCTCTC- (1)
50 CTAGCAGGCAATTCCTCTCTA- (1)
51 TTAGCGGGAAATTCATCTCTT- (1)
*The number of viral cDNA sequences containing each probe is given in
brackets.
doi:10.1371/journal.pone.0017529.t001
Figure 2. Selection of the most representative oligonucleotide
probes.
doi:10.1371/journal.pone.0017529.g002
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neuraminidase represented by 31 cDNA sequences), the first
generation probes Probe_101–Probe_1-3 completely determined
the entire DNA database. In this case, to find more probes (20–24),
iterations were repeated more than five times.
Table 2 shows that with an increased number of iterations, the
number of highly represented probes drops from 1257 to 1107
(Probe_1-1 and Probe_5-1), while the number of poorly
represented probes increases from 33 to 111 (Probe_1-6 and
Probe_5-6).
In addition, there are other ways to select probes. For instance,
to include the least represented sequences (such as H8N1 and
H10N1), the above method could be modified to exclude from
Seq_0 those sequences that match more probes than a pre-set limit
(N_thresh). By varying this parameter, one can change the share of
probes specific to N1 neuraminidase represented by a small
number of DNA sequences. At low N_thresh, the higher number
of DNA sequences from the entire set will match at least N_thresh
probes. In contrast, at high N_thresh, probe selection will be done
essentially as in the first method. In the present example, for all
remaining NA sub-types, sets of 30 probes were selected.
Minimizing cross-subtype hybridization and probe
optimization
To reduce possible false positive hybridization results, oligonu-
cleotide probes were tested for matches to other sub-types after
introduction of one or two nucleotide changes. Table S3 shows the
primary set of probes for the determination of N1 neuraminidase.
Some of these probes demonstrated potential matches with other
sub-types (N2, N3, … N9) with one or two mutations. Therefore,
they were excluded from the set.
It should be noted that even some perfect probes, as well as
probes with one or two mutations, that recognize N1 neuramin-
idase genes can be found in sequences of N2, albeit very rarely
(Table 2). Detailed analysis shows that the only sequence of N2
neuraminidase that binds these N1-specific probes is virus isolate
Influenza A/mallard duck/Minnesota/1979, classified as H3N2.
This sequence does not have any probes (perfect or mismatched by
1 or 2 nucleotides) specific to N2 neuraminidase. On the other
hand, the sequence contains four perfect probes specific to N1. A
similar situation exists for isolates of Influenza A/Equine/New
Market/79 (published as belonging to N3 sub-type but matching
N8 based on oligonucleotide probes pattern), A/ruddy turnstone/
Delaware Bay/262/2006(H7N5) (N5 based on traditional typing,
but N3 based on oligonucleotide probes), and A/Anas plathyr-
hynchos/Spain/1252/2007(H6N4) (N4 vs. N5).
It appears likely that these four examples represent erroneous typing
by conventional methods. Without access to the stocks of these viruses,
it was impossible to directly test this hypothesis. However, independent
phylogenetic analysis confirms that this might be the case. Fig. 3 shows
the phylogenetic tree of a number of DNA sequences of N4 and N5
neuraminidase in which the A/Anas plathyrhynchos/Spain/1252/
2007 isolate is located within the N5 clade.
Finally, to generate probes that would hybridize with their
targets with uniform efficiency their lengths were modified to
adjust the melting temperature of probe-DNA complexes. The
range of melting temperatures was not very restrictive (10uC), and
probe length adjustment included shortening or lengthening of a
probe by 1–2 nucleotides within constant parts of codons.
In silico testing of oligonucleotide probes
Length-modified probes were tested for matching sequences of
other sub-types. Results showed that such modifications did not
lead to the loss of specificity. By using the above procedure, probes
Table 2. Sequences of oligonucleotide probes for sub-typing
of N1 neuraminidase.
Probe_1-1 CAAGAGTCTGAATGTGCATGT 1257 1(2) N2
13(2) N3
2(2) N4
1(1)+1(2) N6
12(1)+10(2) N7
2(2) N9
Probe_1-2 TTTGAGATGATTTGGGATCCT 922 1(1) N2
Probe_1-3 GGGAGTTTTGTCCAGCATCCA 183 1(0) N2
Probe_1-4*** GGTAATGGTGTTTGGATAGGA 91 8(2) N4
1(0)+2(2) N2
Probe_1-5 ATAACAGACACTATCAAGAGT 54 1(0) N2
Probe_1-6*** GGCAATGGTGTTTGGATAGGA 33 8(2) N4
1(1) N2
Probe_2-1 AAAGGGTTTTCATTTAAATAC 1143 1(1) N2
Probe_2-2 AGTGGGAGCAGCATTTCTTTT 827 1(0) N2
Probe_2-3*** GCAAGTGCTTGCCATGATGGC 242 5(2) N8
1(0) N2
Probe_2-4 CACTATGAGGAATGCTCCTGT 164 1(2) N2
Probe_2-5 GCAAGTGCTTGTCATGATGGC 109 1(1)+1(2) N2
Probe_2-6*** TGCAGGGACAACTGGCATGGT 43 15(2) N7
1(1) N2
Probe_3-1 ATAGGATATATATGCAGTGGA 1139
Probe_3-2 TGGGTGTCTTTTAATCAAAAC 803
Probe_3-3 GAGTGCTCCTGTTATCCTGAT 219 1(1)+1(2) N2
Probe_3-4 AAATACGGCAATGGTGTTTGG 129 1(1) N2
Probe_3-5 GGGTACATATGCAGTGGGGTT 101 1(2) N2
Probe_3-6 AGACCTTGCTTCTGGGTTGAA 67
Probe_4-1*** TGGTTGACAATTGGAATTTCT 1112 1(2) N4
1(2) N2
Probe_4-2*** GAATGTTCCTGTTACCCAGAC 774 5(2) N5
Probe_4-3 TGCTCCTGTTATCCTGATGCT 225 1(1) N2
Probe_4-4*** TGCAGGGATAATTGGCATGGC 144 8(2) N7
35(1)+16(2) N9
Probe_4-5 ATAGGGTACATATGCAGTGGG 102
Probe_4-6 ATAGGATACATCTGCAGTGGG 84
Probe_5-1 GGATATATATGCAGTGGAGTT 1107
Probe_5-2 GGAAGTTTCGTTCAACATCCT 739
Probe_5-3*** TTTGAAATGATTTGGGATCCA 210 1(2) N2
3(2) N4
Probe_5-4 AATCGACCTTGGGTGTCTTTT 122 1(2) N2
Probe_5-5 AGTGGGAGCAGCATTTCCTTT 114 1(1) N2
Probe_5-6 CCATACAACTCAAGGTTTGAG 111 1(1) N2
*The total number of cDNA sequences in this analysis was 2623.
**The number of point substitutions in each probe is given in brackets. For
instance, ‘‘1(0) N2’’ is a perfect probe for N9 neuraminidase; ‘‘35(1)+16(2) N9’’
means that 35 and 16 sequences of N9 neuraminidase contain oligonucleotide
probe that differs from the current probe by one or two point substitutions,
respectively.
***Probes that were not used in further experiments.
doi:10.1371/journal.pone.0017529.t002
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S3). The number of probes specific to each sub-type varied
between 19 and 24; a total of 191 probes were selected.
A similar procedure was used for selection of probes to HA
genes, with the exception of H14 for which there were only two
sequences in GenBank (Table S4).
It is noteworthy that both amino acid sequences and primary
DNA structures of the HA gene of H1N1 swine influenza virus
substantially differed from other variants of H1 hemagglutinin.
Therefore, none of the probes selected based on GenBank
sequences deposited prior to March of 2008 matched the DNA
of H1N1 swine influenza. This allowed us to design a set of probes
Figure 3. Phylogenetic tree for cDNA sequences from N4 and N5 neuraminidase isolates.
doi:10.1371/journal.pone.0017529.g003
Microarray Genotyping of Influenza A Virus
PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e17529for selective determination of H1 hemagglutinin of swine H1N1
influenza virus. Structures of these probes are shown in Table S4
(H1_swine). There are no significant differences in neuraminidase
of this virus, and probes identified for N1 sub-type (Table S3) are
suitable for genotyping the NA gene of swine H1N1 virus.
It is important to be able to use the probes for genotyping sub-
types of HA and NA of viruses deposited in GenBank after March
2008 (set 1), i.e., DNA sequences that were not used to generate
probes. Table S5 shows results of in silico testing for N1
neuraminidase in sequences deposited from March 2009–March
2010 (set 2). To minimize bias, only sequences of 1000 nucleotides
or longer were used. The results show that the number of probes
specific to N1 depends on the type of accompanying hemagglu-
tinin. DNA of well-represented subtypes (H1N1 and H5N1) on
average can be determined by 4–5 perfect probes, for both sets 1
and 2. For other sub-types of HA that are less represented, the
average number of perfect probes vary from 2.3 to 5.6, and in
most cases does not depend on the analyzed set of sequences.
Similar conclusions can be made for other sub-types of NA and
HA. This finding suggests that the probes developed in this work
could be used for the genotyping of NA and HA sub-types of
newly isolated strains of Influenza A. On the other hand, this result
does not mean that the probe sets listed in Tables S3 and S4 are
rigidly determined and cannot be expanded or modified. It may be
useful to perform similar analyses in the future as the number of
known sequences expands, closing gaps in the representation of
some sub-types that exist today.
Microarray hybridization
The probes developed in this work were used to create a
microchip containing two sub-arrays. One 1669 spot sub-array
contained NA-specific probes, while another 16624 spot sub-array
contained HA-specific probes (Fig. 4a and 4b). Probes contained
39-amino hexyl linker to enable immobilization on glass slides
modified with phenyl di-isothyocyanate [34]. Microchip edges
were marked with (dT)8 oligonucleotide with 39-amino hexyl linker
and 59-bound fluorescent dye TAMRA.
Microarrays were hybridized with amplicons prepared from
cDNA of Influenza A virus. Because probes were selected from
information regarding full-length sequences of NA and HA, it was
Figure 4. Microarrays layout. A, 2469 spot microarray for sub-typing neuraminidase; B, 24616 spot microarray for sub-typing hemagglutinin.
Each line contains probes specific to individual sub-types of neuraminidase and hemagglutinin. Line number 4 in panel B contains probes specific to
H3 and H1 of swine influenza virus.
doi:10.1371/journal.pone.0017529.g004
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do this, multiplex PCR was used to amplify full-length HA and NA
genes that were then used to generate fluorescently labeled DNA
for hybridization with microarrays.
Multiplex PCR amplification of HA and NA genes of Influenza
A virus was based on primers NA_F1, NA_R2, HA_F1, and
HA_R2 described in [5] that were trimmed at the 59-end. To
increase specificity and the yield of fluorescently labeled DNA for
hybridization, additional internal primers were selected to split
each amplicon into two segments (see Materials and Methods).
Because of the significant sequence diversity, selection of
internal PCR primers was performed in two steps. First, a
conserved 7-mer peptide was chosen and reverse translated into a
degenerate nucleotide sequence corresponding to a set of 21-base
long oligonucleotides coding for this peptide. Amplification was
conducted asymmetrically to generate predominantly single-
stranded DNA for subsequent microchip hybridization.
The microchip created in this work was tested using samples
representing different sub-types of hemagglutinin and neuramin-
idase (Table 3). A total of 40 samples of hemagglutinin genes (H1,
H2, H3, H4, H5, H6, H7, H9, H10, H11, and H13) and 40
samples of neuraminidase (N1, N2, N3, N6, N7, N8) were tested.
The hybridization of fluorescently labeled amplicons was per-
formed at 55–60uC for 2 hours. Microchip slides were then
washed, scanned, and analyzed using ScanArray software. To
assess results of microarray genotyping, two parameters were used:
1. Average fluorescence of a spot (Ym) equal to the total
fluorescence of all spots specific to a sub-type divided by the
number of such spots.
Ym~
X Nm
i
I
m
i
 !,
Nm
where I
m
i represents the fluorescence intensity of the i-th spot for
sub-type m,N m - the total number of spots of sub-type m of NA or
HA.
This parameter was chosen because the analyzed DNA could
not only form perfect duplexes with probes, but also duplexes with
one or two mismatches, providing additional information about
the sub-type of test samples. For instance, for the A/Orenburg/
IIV2974/2009(H1N1) isolate, 6 out of 22 probes can form a
perfect duplex. For the A/Kyoto/07K303/2008(H1N1) isolate,
the number of perfect duplexes is lower (2), but in this case there
are also 7 duplexes with 1 mismatch. At the same time, the
chances of forming stable complexes between these probes and
other sub-types is substantially lower; the rules of probes selection
allowed only three or more mismatches.
2. The fraction of positive spots, i.e., the number of spots specific
to a sub-type with fluorescence exceeding the average fluorescence
of all spots used for genotyping. Even though this parameter is
linked to the first one, it identifies false positive results caused by
high levels of fluorescence. Therefore, both parameters must be
used for the evaluation of results. If both identify the same sub-
type, this increases the reliability of this conclusion.
The error of calculation was determined based on variations in
fluorescence intensity of marker spots located in the left and in the
right columns of the microchip (Fig. 4). This error is integral and
includes all errors related to fabrication, handling, and processing
of the microchips.
Fig. 5 shows examples of hybridization results for amplicons of
HA and NA of Influenza A viruses. It is clear that sub-types of the
isolates can be identified unambiguously. For 36 out of 40 virus
samples tested in this experiment, subtypes of HA and NA were
clearly identified (Table 4). For one of the samples (A/mallard/
Crimea/2027/2006), the subtype of NA was unknown but was
clearly identified as N7. Another sample, A/duck/Primorie/
3691/02, for which there was no NA data in GenBank, yet it was
claimed to be H12N2, the microchip identified the NA as N5.
For two samples of HA from A/Chicken/Novosibirsk region/
326/05 and A/duck/Primorie/3691/02 isolates and the NA from
isolate A/herring gull/Mongolia/454/08, results were ambiguous,
confirming the sub-type only by using one of the two parameters
described above. We also could not determine the sub-type of NA
for A/Wisconsin/67/056Pr/8 X-161 and A/pintail/Kam-
chatka/411/2007 isolates, as well as the HA sub-type for isolates
A/Mallard/Mongolia/2307/2006 and A/mallard/Crimea/
2027/2006.
Interestingly, variations in temperature during hybridization do
not affect hybridization patterns and relative distributions of
intensities across the microchip. A temperature increase above
60uC reduces the number of unspecific spots but leads to the
overall decrease of fluorescence, complicating the analysis and
negatively impacting the overall performance of the test. Similarly,
hybridization at temperatures below 50uC increases binding with
non-specific oligonucleotide probes and leads to smaller differenc-
es between positive and negative spots. At the same time, the 10uC
difference between Tm of different probes did not impact the
performance of respective spots.
In conclusion, this communication describes a new method for
the development of oligonucleotide hybridization probes that
enables the creation of universal microchips for sub-typing HA
and NA genes of Influenza A viruses. Evaluation of these probes,
both in silico by matching them with database sequences and using
them to experimentally identify new virus isolates, demonstrates
high reliability of the proposed probes set for sub-typing HA and
NA genes of Influenza A virus.
Materials and Methods
Nucleotide sequences used in this work (Tables S1 and S2) were
taken from GenBank and NCBI Influenza virus resource (http://
www.ncbi.nlm.nih.gov, http://www.ncbi.nlm.nih.gov/genomes/
FLU/FLU.html).
The selection of probes for sub-typing NA and HA genes was
performed using custom software consisting of a set of Microsoft
Basic macros that implements algorithms described above.
Phylogenetic analysis was performed by version 4.0 of MEGA
software using a neighbor-joining algorithm of cauterization.
Oligonucleotide probes and PCR primers were synthesized using
ASM-800 DNA synthesizer (Biosset Ltd, Novosibirsk, Russia) using
standard protocols. Microarrays were printed on glass phenyl
isothiocyanate slides using Odyssey Calligrapher (BioRad) spotter
with a 360 mm pin. Each slide contained four identical sub-arrays
suitable for simultaneous hybridization of four samples. Each sub-
array contained 9 and 16 lines of spots specific for NA and HA,
respectively. The layout of the probes is shown in Fig. 4.
cDNA of samples 22–40 was produced from genomic RNA
isolated from 140 ml of tissue culture fluid (virus titer 105–
107 PFU/ml) using QIAquick Viral RNA Kit (QIAGEN,
Valencia, CA). Reverse transcription was performed as follows.
The mixture containing 1 ml of GACTAATACGACTCACTA-
TAGGGAGCAAAAGCAGG primer (20 mM), 9 ml RNA extract-
ed from 80 ml of virus, and 2 ml of the dNTP (10 mM) mixture was
heated for 10 min at 65uC and chilled on ice. Next, 4 mlo f5 6
cDNA buffer, 1 ml water, and 1 ml of ThermoScript (Invitrogen,
Carlsbad, CA) reverse transcriptase were added. The mixture was
centrifuged and incubated for 5 min at 55uC and 55 min at 60uC.
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No - Isolate
Virus
sub-type Taxon HA NA
Accession
Number 1
Successful
genotyping call
Accession
Number 1
Successful
genotyping call
1 A/goose/Krasnoozerka/627/2005* H5N1 434196 DQ676840 (+) EF205171 (+)
2 A/duck/Tuva/01/06* H5N1 399313 DQ861291 (+) DQ861293 (+)
3 A/turkey/Suzdalka/12/05* H5N1 434198 EF205158 (+) EF205172 (+)
4 A/Anas platyrhynchos/Chany Lake/9/03* H5N3 326856 DQ007623 (+) N/A (+)
5 A/Chicken/Novosibirsk region/326/05* H2N2 N/A N/A (+/2) N/A (+)
6 A/Domestic Duck/Novosibirsk region/41/05* H4N6 N/A N/A (+) N/A (+)
7 A/Mallard/Mongolia/2307/2006* H1N1 N/A N/A (2) N/A (+)
8 A/Solomon Islands/3/2006* H1N1 464622 EU124137 (+) EU124136 (+)
9 A/Irkutsk/165* H6N1 N/A N/A (+) N/A (+)
10 A/Altay/1324/2007* H3N8 N/A N/A (+) N/A (+)
11 A/mallard/Irkutsk/170/08* H6N1 N/A N/A (+) N/A (+)
12 A/Pochard/Siberia/249/08* H10N7 N/A N/A (+) N/A (+)
13 A/herring gull/Mongolia/454/08* H13N8 N/A N/A (+) N/A (+/2)
14 A/pintail/Kamchatka/411/2007* H7N1 N/A N/A (+) N/A (2)
15 A/mallard/Crimea/2027/2006* H7N? N/A N/A (2) N/A (+)N 7
16 A/duck/Primorie/3691/02** H12N2 397550 DQ787811 (+/2) N/A (+)N 5
17 A/teal/Primorie/3628/02** H9N2 397546 DQ787797 (+) N/A (+)
18 A/Moscow/IIV04/2009** H1N1 swine 660123 GQ392022 (+) GQ392023 (+)
19 A/Moscow/IIV05/2009** H1N1 swine 667050 GQ494354 (+) GQ494353 (+)
20 H10N7** H10N7 N/A N/A (+) N/A (+)
21 H11N6** H11N6 N/A N/A (+) N/A (+)
22 A/New Caledonia/20/91vr 116 H1N1 N/A N/A (+) N/A (+)
23 A/New Caledonia/20/1999 H1N1 381512 CY033622 (+) CY033624 (+)
24 A/Texas/36/91 H1N1 380964 CY009316 (+) CY009318 (+)
25 A/Texas/36/91 X-113 H1N1 380964 CY033655 (+) CY033600 (+)
26 A/Solomon Islands/3/06 H1N1 464623 CY031340 (+)( +)
27 A/Solomon Islands/3/06 Ivr-145 H1N1 N/A N/A (+) N/A (+)
28 A/St. Petersburg/08/2006 X-163 H1N1 461815 EU100725 (+) N/A (+)
29 A/St. Petersburg/08/2006 X-163B H1N1 461817 EU100727 (+) N/A (+)
30 A/Sydney/05/97 H3N2 587884 AF087709 (+) N/A (+)
31 A/Sydney/05/97 Ivr-108 H3N2 N/A N/A (+) N/A (+)
32 A/Wisconsin/67/05 H3N2 393902 CY034118 (+) CY034116 (+)
33 A/Wisconsin/67/056Pr/8 X-161 H3N2 N/A N/A (+) N/A (2)
34 A/Wy/03/036A/Pr/8/34 H3N2 N/A N/A (+) N/A (+)
35 A/Wyoming/03/2003 H3N2 480024 EU501362 (+) N/A (+)
36 A/New York/55/04 H3N2 518981 CY033638 (+) CY033640 (+)
37 A/Ny/55/046Pr/8 X-157a H3N2 N/A N/A (+) N/A (+)
38 A/Pr8/34 H1N1 211044 CY033577 (+) CY033579 (+)
39 A/Wuhan/359/1995 H3N2 63106 EU501120 (+) N/A (+)
40 A/Wsn/1933 H1N1 382835 CY034132 (+) CY034134 (+)
1For some samples obtained from Vektor and D.I.Ivanovsky Institute virus collections GenBank Accession numbers are unavailable.
(+) – sub-type call was made by using two parameters: average fluorescence of a spot and fraction of positive spots. In cases of discrepancy with previously determined
genotype the new genotype is indicated.
(+/2) – sub-type call was made by one parameter: average fluorescence of a spot.
(2) – sub-type could not be determined.
*– cDNA of the Influenza A virus provided by Dr. E.M. Shestopalova, Vektor, Novosibirsk.
**– cDNA of the Influenza A virus provided by Dr. A.G. Prilipov, D.I.Ivanovsky Institute of Virology, Moscow.
doi:10.1371/journal.pone.0017529.t003
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primes were used:
NA_F1: 59-CTATAGGGAGCAAAAGCAGGAGT-39
NA_R2: 59-CACTATAGAAGTAGAAACAAGGAGTTTTTT-39
HA_F1: 59-GACTCACTATAGGGAGCAAAAGCAGGGG-39
HA_R1: 59-GGTGACACTATAGAAGTAGAAACAAGGGT-
GTTTT-39
The 50 ml of PCR mixture contained Qiagen PCR buffer
(1.5 mM MgCl2, KCl, (NH4)2SO4, tris-HCl, pH 8.7), 1.5 mM
MgCl2, 200 mM dATP, dCTP dGTP, dTTP, 1 mM of each
primer, 1.25 U of Qiagen Hot Start Taq-polymerase, and 2 mlo f
template DNA solution. PCR was performed using iCycler
(BioRad) with the described protocol: 15 min at 95uC followed
by 42 cycles including 30 sec at 94uC, 30 sec at 58uC, and 5 min
at 72uC.
To generate fluorescently labeled fragments, the following pairs
of primers were used:
NA_F1: 59-CTATAGGGAGCAAAAGCAGGAGT-39
NA_R1: 59-TAACAGGARCAYTCCTCRTARTG-39
NA_F2: 59-CAYTAYGAGGARTGYTCCTGTTA-39
NA_R2: 59-CACTATAGAAGTAGAAACAAGGAGTTTTTT-39
HA_F1: 59-GACTCACTATAGGGAGCAAAAGCAGGGG-39
HA_R1: 59-59-TCWATRAANCCNGCDATDGCHCC-39
HA_F2: 59-GGDGCHATHGCNGGNTTYATWGA-39
HA_R1: 59-GGTGACACTATAGAAGTAGAAACAAGGG-
TGTTTT-39
The amplicon lengths were ,800 and ,600 b.p. for neuramin-
idase and ,1,100 and ,700 b.p. for hemagglutinin. To generate
predominantly single-stranded DNA for subsequent hybridization,
asymmetric DNA was performed [12]. The composition of PCR
mixture included (per 50 ml) Qiagen PCR buffer (1.5 mM MgCl2,
KCl, (NH4)2SO4, tris-HCl, pH 8.7), 1.5 mM MgCl2, 200 mM
dATP, dCTP dGTP, 70 mM dTTP, 20 mM dUTP-Cy3, 80 nM or
forward primer, 1 mM of reverse primer, 1.25 U of Qiagen Hzot-
Start Taq-polymerase, and 1 ml of full length amplicon template.
PCR was performed in a BioRad iCycler under the following
conditions: 15 min at 95uC followed by 34 cycles consisting of
30 sec at 94uC, 30 sec at 52–55uC, and 80 sec at 72uC. The
amplification was monitored by electrophoresis in 1% agarose gel
with EtBr staining. Fluorescently labeled amplicons were clarified
from the excess of dNTPs using Qiagen gel filtration columns and
were further dried in a vacuum centrifuge at 60uC.
The dried fluorescently labeled amplicons were reconstituted in
10 ml of water, supplemented with 10 mlo f2 6hybridization buffer,
heated for 2 min at 97uC, and chilled on ice before hybridization.
16hybridization buffer contained 66SSC, 56Denhardt solution,
and 0.1% Tween 20. Hybridization was performed in an ArrayIt
chamber (Sunnyvale, CA) at 55–60uC for 2 hours. Next, slides were
subsequently washed in 66SSC, 26SSC with 0.2 fi SDS, 26SSC,
and 16 SSC. Slides were scanned using Scan Array Express 2.0
(Perkin Elmer) at 543 nm (Cy3) and 633 nm (Cy5). The images
were analyzed with ScanArray Express software (Perkin Elmer).
Supporting Information
Table S1 The number of isolates of Influenza A viruses
with different sub-types of neuraminidase analyzed in
this work.
(XLS)
Table S2 The number Influenza A virus isolates with
different hemagglutinin sub-types tested in this work.
(XLS)
Table S3 Sequences of oligonucleotide probes for sub-
typing of neuraminidase of Influenza A virus. Oligonu-
cleotide probes are shown in 59-3 9 direction.
(XLS)
Table S4 Sequences of oligonucleotide probes for sub-
typing of Influenza A virus hemagglutinin. Oligonucleotide
probes are
(XLS)
Table S5 Effectiveness of N1 neuraminidase sub-typing
by using oligonucleotide probes. Probes specific for N1
neuraminidase (see Table 5) and cDNA of neuraminidase longer
than 1,000 nucleotides were used.
(XLS)
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Table 4. Summary results of sub-typing of Influenza A
isolates.
Sub-type Total (+)( 2)( +/2) Sub-type Total (+)( 2)( +/2)
H1 12 11 1 - N1 20 19 1
H1_swine 2 2 - - N2* 12 10 1 1
H2 1 1 - 1 N3 1 1
H3 10 10 - - N4 -
H4 1 1 - - N5 -
H5 4 4 - - N6 2 2
H6 2 2 - - N7 2 2
H7 2 1 1 - N8 2 1 1
H8 - 1 - - N9 -
H9 1 1 - - N?** 1 1
H10 2 2 - -
H11 1 1 - -
H12 1 1
H13 1 1 - -
Total 40 36 2 2 40 36 2 2
*One of isolates tests as N5.
**Sub-type of NA was unknown, but was determined to be N7.
(+) – sub-type call was made by using two parameters.
(+/2) – sub-type call was made by one parameter (average fluorescence of a
spot).
(2) – sub-type could not be determined.
doi:10.1371/journal.pone.0017529.t004
Figure 5. Microarray hybridization pattern obtained for amplicons of different sub-types of neuraminidase and hemagglutinin of
the Influenza A virus and respective histograms showing average fluorescence of individual microchip elements. Hybridization was
performed for 2 hours at 55uC.
doi:10.1371/journal.pone.0017529.g005
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